Zager R A
Department of Medicine, University of Washington, Seattle.
Kidney Int. 1988 Jan;33(1):84-90. doi: 10.1038/ki.1988.13.
The purpose of this study was to determine whether a retained focus of necrotic tissue predisposes to aminoglycoside-induced acute renal failure (ARF). Rats were subjected to either (1) 25% liver ligation, creating a focus of ischemic tissue which was left in place; (2) 25% liver resection; or (3) sham liver ligation. Gentamicin, 80 mg/kg bid, was administered for two days after surgery to all three groups. A fourth group was subjected to 25% liver ligation but no gentamicin therapy. Only rats subjected to partial liver ligation plus gentamicin treatment developed ARF, manifested by azotemia (BUN 80 +/- 2; creatinine 1.63 +/- 0.21; mg/dl) and tubular necrosis. This occurred in the absence of any discernible reduction in arterial blood pressure, renal blood flow, excessive weight loss, or ascites formation. The partial liver ligation-gentamicin group had 70% higher renal gentamicin concentrations than the liver resection-gentamicin controls (P = 0.01). To assess whether factors released from necrotic liver might account for these findings, additional rats were infused with: (1) 1 ml of a soluble liver extract alone; (2) 1 ml of liver extract plus gentamicin; or (3) 1 ml of saline plus gentamicin. Only the liver extract/gentamicin group developed ARF (BUN 88 +/- 13; creatinine 1.46 +/- 0.25). This occurred in association with a 110% increase in renal gentamicin uptake (P less than 0.03). In separate experiments, 5 ml liver extract infusions caused ARF (BUN 118 +/- 7; creatinine 2.1 +/- 0.18) without gentamicin treatment. In conclusion, a focus of liver necrosis can predispose to experimental gentamicin nephrotoxicity.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是确定坏死组织的残留病灶是否会引发氨基糖苷类药物所致的急性肾衰竭(ARF)。将大鼠分为三组,分别进行如下处理:(1)25%肝结扎术,形成缺血组织病灶并保留;(2)25%肝切除术;(3)假肝结扎术。术后,对所有三组大鼠均给予庆大霉素,剂量为80mg/kg,每日两次,持续两天。第四组大鼠进行25%肝结扎术,但不给予庆大霉素治疗。只有接受部分肝结扎术加庆大霉素治疗的大鼠出现了ARF,表现为氮质血症(血尿素氮80±2;肌酐1.63±0.21;mg/dl)和肾小管坏死。这一情况发生时,动脉血压、肾血流量均无明显降低,也没有过度体重减轻或腹水形成。部分肝结扎 - 庆大霉素组的肾脏庆大霉素浓度比肝切除 - 庆大霉素对照组高70%(P = 0.01)。为评估坏死肝脏释放的因子是否能解释这些结果,给另外的大鼠输注:(1)仅1ml可溶性肝提取物;(2)1ml肝提取物加庆大霉素;(3)1ml生理盐水加庆大霉素。只有肝提取物/庆大霉素组出现了ARF(血尿素氮88±13;肌酐1.46±0.25)。这一情况伴随着肾脏对庆大霉素摄取增加110%(P<0.03)。在单独的实验中,输注5ml肝提取物在未给予庆大霉素治疗的情况下也导致了ARF(血尿素氮118±7;肌酐2.1±0.18)。总之,肝坏死病灶可引发实验性庆大霉素肾毒性。(摘要截断于250字)